Draft guideline on manufacturing site transfer requirements for immunobiological products

This draft document was published for consultation starting 18 December 2019, ending 28 February 2020.

Was this page helpful?

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.

CAPTCHA